In addition, Sigmar1’s chaperone activity has been reported to degrade intranuclear inclusions and provide neuroprotection in Huntington’s disease, Alzheimer’s disease, and Parkinson’s disease (Miki et al., 2014, 2015; Yamoah et al., 2020). This evidence concerns the gene SIGMAR1 and Parkinson disease.